Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healwell AIHWAIF -2.14%53 Debt-to-EBITDA is 16.67 as of Mar. 2026. GuruFocus rates HWAIF with a GF Score™ of 53/100 and a GF Value™ of $2.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Healwell AI ranks worse than 209204.81% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Healwell AI's Debt-to-EBITDA or its related term are showing as below:
HWAIF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -34.61 Med: -1 Max: 7.12
Current: -34.61
During the past 9 years, the highest Debt-to-EBITDA Ratio of Healwell AI was 7.12. The lowest was -34.61. And the median was -1.00.
HWAIF's Debt-to-EBITDA is ranked worse than 100% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs HWAIF: -34.61
Healwell AI (OTCPK:HWAIF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Healwell AI Debt-to-EBITDA Related Terms
Healwell AI Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Healwell AI's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Healwell AI's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healwell AI Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healwell AI's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Healwell AI's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Healwell AI (HWAIF) has a Debt-to-EBITDA of 16.67 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Healwell AI. According to the industry distribution chart, Healwell AI ranks #999999 out of 478 companies in the Healthcare Providers & Services industry.
Is Healwell AI's Debt-to-EBITDA too high?
Healwell AI's current Debt-to-EBITDA is 16.67. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Healwell AI's value of 16.67 is 640.9% above this industry median. Based on the distribution chart, Healwell AI ranks #999999 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Healwell AI has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healwell AI's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Healwell AI ranks #999999 out of 478 companies for Debt-to-EBITDA. This places Healwell AI in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Healwell AI's value of 16.67 is 640.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healwell AI's current Debt-to-EBITDA of 16.67 is 640.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Healwell AI. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healwell AI's current Debt-to-EBITDA is 16.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healwell AI stock overvalued right now?
Based on GuruFocus' analysis, Healwell AI (HWAIF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.54, compared to a current price of $0.47 — trading 81.6% below its estimated fair value. The current Debt-to-EBITDA is 16.67 and 640.9% above the Healthcare Providers & Services industry median of 2.25. Healwell AI's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Healwell AI (HWAIF), the current Debt-to-EBITDA is 16.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healwell AI (HWAIF) Overvalued in 2026?
Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued.
The current stock price of $0.47 is trading 81.6% below its estimated GF Value™ of $2.54.
GuruFocus considers Healwell AI to be Possible Value Trap.
Key valuation signals for HWAIF:
Debt-to-EBITDA: 16.67
GF Value™: $2.54 vs. price of $0.47 (81.6% below fair value)
Industry Position: 640.9% above the Healthcare Providers & Services median (#999999 of 478)
No single metric tells the full story. See the HWAIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
53GF Score
Get the complete analysis for HWAIF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HWAIF has been successfully added to your 
